Benign neoplasm of tongue
ICD-10 D10.1 is a billable code used to indicate a diagnosis of benign neoplasm of tongue.
Benign neoplasms of the tongue are non-cancerous growths that can arise from various tissues within the tongue, including muscle, connective tissue, and mucosal epithelium. These neoplasms may present as asymptomatic masses or lesions, and they can vary in size and appearance. Common types include fibromas, lipomas, and papillomas. While benign, these neoplasms can cause discomfort, difficulty in swallowing, or speech issues depending on their size and location. Surveillance is essential, as some benign lesions may have the potential for malignant transformation, particularly if they exhibit atypical features or if there is a history of chronic irritation. Regular follow-up with clinical examinations and imaging may be warranted to monitor any changes in size or characteristics. Treatment often involves surgical excision, especially if the neoplasm is symptomatic or if there is uncertainty regarding its nature. Accurate coding is crucial for appropriate management and reimbursement, as well as for tracking the incidence of these lesions in the population.
Detailed descriptions of the lesion, including size, location, and symptoms.
Evaluation of a patient with a tongue mass, biopsy results indicating a benign neoplasm.
Ensure that the pathology report is included in the documentation to support the diagnosis.
Surgical notes detailing the excision procedure and histopathological findings.
Surgical removal of a benign tongue neoplasm due to size or symptomatic concerns.
Document the rationale for surgery and any pre-operative imaging results.
Used when a benign neoplasm is surgically removed.
Surgical notes must detail the procedure and findings.
Otolaryngologists and oral surgeons should ensure accurate coding based on the type of neoplasm excised.
Common types include fibromas, lipomas, and papillomas. Each type may present differently and require specific management.
Surveillance frequency depends on the size and characteristics of the neoplasm, but regular follow-ups are recommended to monitor for any changes.
